Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/2, Open-Label Clinical Trial To Assess The Safety Of The Acellular Vascular Graft ATEV In Infants With Discontinuous Pulmonary Arteries Requiring Conduit Placement

NCT07785661 is registered in ClinicalTrials.gov with Joseph Dearani as lead sponsor.

NCT NCT07785661
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07785661 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/2, Open-Label Clinical Trial To Assess The Safety Of The Acellular Vascular Graft ATEV In Infants With Discontinuous Pulmonary Arteries Requiring Conduit Placement
Lead sponsor
Joseph Dearani
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
August 31, 2030
Enrollment
6 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

absent pulmonary artery